Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study

PURPOSE: Rising melanoma incidences lead to an increasing need for individual therapy strategies in old patients. Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, approved for the local treatment of unresectable metastatic melanoma. Since data on the efficacy and safety of geriat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleemann, Johannes, Jäger, Manuel, Valesky, Eva, Kippenberger, Stefan, Kaufmann, Roland, Meissner, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289688/
https://www.ncbi.nlm.nih.gov/pubmed/34290528
http://dx.doi.org/10.2147/CMAR.S286917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289688/
https://www.ncbi.nlm.nih.gov/pubmed/34290528
http://dx.doi.org/10.2147/CMAR.S286917

Ejemplares similares